Insider Tracker SEC Form 4 insider trades
← All clusters
AGMB

AgomAb Therapeutics NV

Healthcare Biological Products, (No Diagnostic Substances) Market cap: not available All insider activity → Quote and statistics → Sign in to watch AGMB Sign in to set a price alert
62
Insider Score Band 60–79

Research score, not a recommendation.

Total bought$311.2K8 Form 4 purchases
Distinct insiders3open-market buyers
Lead insiderKnotnerus Tim JasperCEO
Cluster window2026-10-05 → 2026-10-08active

Market data

Live quote and chart from Yahoo Finance, loaded through this server. Insider purchases are marked on the chart.

–

partial data Market cap is missing; missing inputs count as neutral in the score.

Why this score

Research score: a weighted blend of the five factors, times the routine and offering discounts, minus the selling penalty.

Breadth number & diversity of participating insiders
37%
Seniority executive rank of buyers (CEO/CFO/Director)
92%
Commitment purchase size relative to company & holdings
70%
Context buying into stock weakness signals conviction
98%
Timing coordinated purchases within a tight window
100%
Routine-purchase discount × 1.00
Company-type / offering discount × 1.00
Net insider selling penalty − 0

Why are they buying?

No explanation has been generated for this cluster. The filings in the table below are the primary evidence.

Stock Price & Insider Purchase History

Daily close price with open-market insider purchases plotted over time

Loading price history…

Transactions

8 Form 4 trades · 3 insiders Sign in to download CSV
Purchases in this cluster, grouped by insider, largest first
Date Insider Role Shares Price Value Filing
2026-10-05 → 2026-10-08 Epstein David R history of Epstein David R's purchases Director 15,000 $8.72 avg $130.8K
2026-10-05 Epstein David R 5,000 $8.57 $42.9K SEC filing for Epstein David R (opens in a new tab)
2026-10-06 Epstein David R 5,000 $8.70 $43.5K SEC filing for Epstein David R (opens in a new tab)
2026-10-08 Epstein David R 5,000 $8.90 $44.5K SEC filing for Epstein David R (opens in a new tab)
2026-10-05 → 2026-10-06 Knotnerus Tim Jasper history of Knotnerus Tim Jasper's purchases CEO 11,000 $8.58 avg $94.4K
2026-10-05 Knotnerus Tim Jasper 6,000 $8.48 $50.9K SEC filing for Knotnerus Tim Jasper (opens in a new tab)
2026-10-06 Knotnerus Tim Jasper 5,000 $8.70 $43.5K SEC filing for Knotnerus Tim Jasper (opens in a new tab)
2026-10-06 Kemula Pierre Thadee Victor history of Kemula Pierre Thadee Victor's purchases CFO 10,000 $8.59 avg $85.9K
2026-10-06 Kemula Pierre Thadee Victor 2,000 $8.54 $17.1K SEC filing for Kemula Pierre Thadee Victor (opens in a new tab)
2026-10-06 Kemula Pierre Thadee Victor 5,000 $8.57 $42.9K SEC filing for Kemula Pierre Thadee Victor (opens in a new tab)
2026-10-06 Kemula Pierre Thadee Victor 3,000 $8.67 $26.0K SEC filing for Kemula Pierre Thadee Victor (opens in a new tab)
Total $311.2K

What happened next

A run ends after a pause in the buying, so one company can have several. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.

After this run became a cluster: 21 days –63 days –126 days –